Official ESCRS | European Society of Cataract & Refractive Surgeons

 

Blended vision with Oculentis Mplus X MF30 and Oculentis Mplus MF20: the visual outcome and patient satisfaction of 150 patients

Search Title by author or title

Session Details

Session Title: Presented Poster Session: Enlarged Depth of Focus vs Multifocal IOLs

Venue: Poster Village: Pod 1

First Author: : K.Kok Khiang MALAYSIA

Co Author(s): :                           

Abstract Details

Purpose:

To assess the 1 month postoperative visual performance and subjective patient satisfaction in 150 patients with bilateral implantation with Oculentis Mplus X MF30 and Oculentis Mplus MF20.

Setting:

Vista Eye Specialist Clinic, Malaysia.

Methods:

This study comprised 150 patients (300 eyes) who had successful bilateral femtosecond laser assisted cataract / clear lens surgery with implantation of Oculentis MplusX 30 in the non-dominant eye and Oculentis Mplus MF20 in the dominant eye. The surgery on each eye had been done on consecutive days. Parameters analysed included binocular uncorrected visual acuity for distance, intermediate and near, spectacle independence, photic phenomena and patient satisfaction.

Results:

At post-op 1 month, the mean bilateral UCDVA was 0.03±0.06 logMAR with 94% (141 patients) achieving 20/25 (6/7.5) or better (p<0.001), mean bilateral UCIVA was -0.04±0.07 logMAR with 100% (150 patiens) achieving 20/25 or better (p<0.001) and mean bilateral UCNVA was 0.04±0.06 logMAR with 100% (150 patients) achieving J3 (N5) or better (p<0.001). Most of the patients did not wear glasses for daily activities and reported high satisfaction especially less glares and no haloes in overall performance.

Conclusions:

The study showed that with bilateral implantation of Oculentis Mplus X MF30 and Oculentis Mplus MF20 provide very good uncorrected visual acuity for distance, intermediate and near. This blended vision approach has achieved very high patient satisfaction and most patient have been practically spectacle independence with close to minimal to none visual disturbances reported.

Financial Disclosure:

None

Back to previous